Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Lilly Ventures leads $24M round for Cerulean's PhII
Fierce Biotech
Monday, November 15, 2010 - 10:51am
tags:
Eli Lilly, financing, Cerulean, Series C, lung cancer
Benlysta review spooks investors ahead of FDA panel
Fierce Biotech
Monday, November 15, 2010 - 10:48am
tags:
FDA, advisory panels, Benlysta, Human Genome Sciences, lupus
At AstraZeneca, 15,000 Layoffs May Not Be Enough
BNET Pharma
Monday, November 15, 2010 - 10:42am
tags:
layoffs, AstraZeneca
Bayer Sees $2.73 Billion Peak Xarelto Sales as ’Conservative’
Bloomberg
Monday, November 15, 2010 - 10:40am
tags:
Bayer, Xarelto, blood thinners
Genzyme in Talks to Sell Itself to Japan’s Takeda, Mail Says
Bloomberg
Monday, November 15, 2010 - 10:39am
tags:
Takeda, Genzyme, M&A
UCB Falls Most in Six Months as UBS Downgrades, Says Takeover Is Unlikely
Bloomberg
Monday, November 15, 2010 - 10:38am
tags:
UCB Pharmaceuticals, M&A, Cimzia, Pfizer, rheumatoid arthritis
AstraZeneca Defeats Teva's Unusual Patent Claim
Seeking Alpha
Monday, November 15, 2010 - 10:37am
tags:
Teva Pharmaceuticals, patents, AstraZeneca, Crestor
Surprise: JNJ Heart Drug Doesn’t Kill People. Or Do Much Of Anything.
Forbes
Sunday, November 14, 2010 - 1:31pm
tags:
JNJ, congestive heart failure, Natrecor
Moody’s Downgrade Adds to Eli Lilly's Growing Burden
Seeking Alpha
Sunday, November 14, 2010 - 1:30pm
tags:
Eli Lilly
Big pharma’s Brazilian prescription
Financial Times, UK
Sunday, November 14, 2010 - 1:29pm
tags:
Big Pharma, Brazil
Morgan Stanley unenthusiastic on Teva share
Globes, Israel
Sunday, November 14, 2010 - 1:28pm
tags:
Teva Pharmaceuticals
Avanir Pharmaceuticals (AVNR) Institutional Ownership Increases
Wall Street NewsCast
Sunday, November 14, 2010 - 1:27pm
tags:
Avanir
AcelRx Pharmaceuticals Files Registration Statement for Proposed Initial Public Offering
PR-USA.net
Sunday, November 14, 2010 - 1:25pm
tags:
AcelRx, pain management
MethylGene Reports Third Quarter 2010 Financial Results and Provides Clinical Update for MGCD265
PR-USA.net
Sunday, November 14, 2010 - 1:09pm
tags:
MethylGene, earnings, Otsuka, MGCD265, cancer
London Genetics and Astrimmune to Collaborate on Cancer Vaccine
PipeLine Review
Sunday, November 14, 2010 - 1:06pm
tags:
London Genetics, Astrimmune, cancer vaccines
Takeda and Sage Bionetworks Form CNS disease Research Alliance
PipeLine Review
Sunday, November 14, 2010 - 1:05pm
tags:
Takeda, Sage Bionetworks, CNS
Pozen Announces Achievement of $25 Million Milestone From AstraZeneca For VIMOVO(TM)
PipeLine Review
Sunday, November 14, 2010 - 1:04pm
tags:
Pozen, Vimovo, AstraZeneca, NSAIDs
Pfizer: Trading Below Reproduction Value?
Seeking Alpha
Sunday, November 14, 2010 - 12:51pm
tags:
Pfizer
Eli Lilly and the Cyclical Business of Drug Development
Seeking Alpha
Sunday, November 14, 2010 - 12:50pm
tags:
Eli Lilly, pipelines, R&D
Adding INSPRA® (eplerenone) to Standard Therapy Significantly Reduces the Risk of CV Mortality and Morbidity in Patients With Chronic Heart Failure With Mild Symptoms, Study Shows
Yahoo/PR NewsWire
Sunday, November 14, 2010 - 12:48pm
tags:
Inspra, heart failure, Pfizer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.